Download PDF
TumorDiagnostik & Therapie 2015; 36(07): 394-397
DOI: 10.1055/s-0035-1552323
Schwerpunkt: Schilddrüsenkarzinome
Georg Thieme Verlag KG Stuttgart · New York

Übersicht – Diagnostik von Schilddrüsentumoren

A. Pfestroff
,
M. Luster
Further Information

Publication History

Publication Date:
29 October 2015 (online)

Also available at
    Permissions and Reprints

Tumoren im Sinne einer malignen Raumforderung lassen sich nach Maßgabe des histopathologischen Befundes einteilen in gut differenzierte Schilddrüsenkarzinome (papillär und follikulär bzw. PTC und FTC), schlecht differenzierte Schilddrüsenkarzinome (PDTC), undifferenzierte bzw. anaplastische Schilddrüsenkarzinome (ATC) und medulläre Schilddrüsenkarzinome (MTC).

 

  • Literatur

  • 1 Völzke H, Lüdemann J, Robinson DM et al. The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area. Thyroid 2003; 13: 803-810
    CrossrefPubMedGoogle Scholar
  • 2 Wiest PW. Thyroid palpation versus high-resolution thyroid ultrasonography in the detection of nodules. J Ultrasound Med 1998; 17: 487-496
    PubMedGoogle Scholar
  • 3 Remonti LR, Kramer CK, Leitäo CB et al. Thyroid Ultrasound Features and Risk of Carcinoma: A Systematic Review and Meta-Analysis of Observational Studies. Thyroid 2015; 25: 538-550
    CrossrefPubMedGoogle Scholar
  • 4 Ruhlmann M, Stebner V, Görges R et al. Diagnostik hyperfunktioneller Schilddrüsenknoten. Bedeutung der US-Elastographie. Nuklearmedizin 2014; 53: 173-177
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Dietlein M, Eschner W, Lassmann M et al. Procedure guideline for thyroid scintigraphy (Version 4). Nuklearmedizin; 2014
    PubMedGoogle Scholar
  • 6 Schicha H, Hellmich M, Lehmacher W et al. Should all patients with thyroid nodules ≥ 1 cm undergo fine-needle aspiration biopsy?. Nuklearmedizin 2009; 48: 79-83
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Nikiforov YE, Nikiforova MN. Molecular genetics and diagnosis of thyroid cancer. Nat Rev Endocrinol 2011; 7: 569-580
    CrossrefPubMedGoogle Scholar
  • 8 Schneider C, Kobe C, Schmidt M et al. Calcitonin screening in patients with thyroid nodules. Diagnostic value. Nuklearmedizin 2012; 51: 228-233
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Sawka AM, Thephamongkhol K, Brouwers M et al. Clinical review 170: A systematic review and metaanalysis of the effectiveness of radioactive iodine remnant ablation for well-differentiated thyroid cancer. J Clin Endocrinol Metab 2004; 89: 3668-3676
    CrossrefPubMedGoogle Scholar
  • 10 Luster M, Karges W, Zeich K et al. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography / computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 2010; 20: 527-533
    CrossrefPubMedGoogle Scholar
  • 11 Luster M, Weber T, Verburg FA. Differentiated thyroid cancer-personalized therapies to prevent overtreatment. Nat Rev Endocrinol 2014; 10: 563-574
    CrossrefPubMedGoogle Scholar